Navigation Links
NPC Conference to Address Questions on Ability to Share Health Research Findings

WASHINGTON, Feb. 6, 2012 /PRNewswire-USNewswire/ -- To examine key issues around asymmetries, or inequalities, in communicating health information coming from the growing body of comparative effectiveness research (CER), the National Pharmaceutical Council, the National Health Council and WellPoint are sponsoring a conference, Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making. 

With billions of dollars in funding being invested in comparative effectiveness research, patients, providers, payers and other health care decision-makers will have more information than ever before about the safety and effectiveness of treatment options. However, not all stakeholders have equal ability to share information in the current regulatory environment. The conference will facilitate discussion about the information needs of patients, payers and other stakeholders, and how the First Amendment and other legal issues apply. Presenters will share with attendees a proposed ethical framework for communicating CER information.

Who: Confirmed speakers include:

  • Arthur Caplan, PhD, Director, Center for Bioethics, University of Pennsylvania
  • Susan Dentzer, Editor-in-Chief, Health Affairs/Project HOPE
  • Robert W. Dubois, MD, PhD, Chief Science Officer, National Pharmaceutical Council
  • Scott Gottlieb, MD, Resident Fellow, American Enterprise Institute
  • Stephen Hume, PsyD, Alzheimer's patient representative, and his care partner, Candace Darcy
  • Aaron S. Kesselheim, MD, JD, MPH, Assistant Professor of Medicine, Harvard Medical School
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
  • Joshua D. Lenchus, DO, RPh, FACP, Associate Director, University of Miami-Jackson Memorial Hospital Center for Patient Safety, and Associate Professor of Medicine, University of Miami Miller School of Medicine
  • Gerald F. Masoudi, Partner, Covington & Burling LLP
  • Steven J. Romano, MD, Senior Vice President, Head, Medicines Development Group, Primary Care Business, Pfizer Inc
  • Robert J. Temple, MD, Deputy Center Director for Clinical Science, U.S. Food and Drug Administration's (FDA's) Center for Drug Evaluation and Research, and Acting Deputy Director of the FDA's Office of Drug Evaluation I
  • Tevi Troy, PhD, Senior Fellow, Hudson Institute, and former Deputy Secretary, U.S. Department of Health and Human Services
  • Marcus Wilson, PharmD, President, HealthCore

When: Thursday, February 9, 2012, from 9:30 a.m. to 4:30 p.m.  The conference will open at 8:30 a.m. for registration and a continental breakfast.

Where:  Omni Shoreham Hotel, 2500 Calvert St. NW, Washington, D.C.  

Registration is complimentary at     

To join the conversation on Twitter, use the hashtag #asym12.

SOURCE National Pharmaceutical Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Webcast Alert: Heska Announces Fourth Quarter and Year-End 2011 Earnings Conference Call Webcast
2. Stryker Presents Results of the TREVO Prospective Clinical Study at the International Stroke Conference
3. American Pacific to Release Financial Results and Hold Fiscal 2012 First Quarter Investor Teleconference
4. CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial Results
5. Winner Medical Group Inc. to Host First Quarter 2012 Earnings Conference Call on Thursday, February 9, 2012 at 08:00 p.m. EST
6. Vision-Sciences, Inc. to Webcast, Live, at on February 2nd
7. ThermoGenesis Provides Update on Res-Q® Clinical Evaluations at Leading Stem Cell Therapy Conference
8. Hill-Rom to Participate in the Leerink Swann 2012 Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference
10. Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012
11. Palomar Medical Technologies to Host Fourth Quarter and Year End 2011 Financial Results Conference Call and Webcast on February 9, 2012 at 11:30 AM Eastern Time
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the Global Cell Surface Testing Market: ... report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... --> ... att använda SyMRI för att hitta optimal ... med multipel skleros (MS) eller hjärntumörmetastaser och ... för att kunna använda SyMRI Research Edition ... kan man generera flera konstrastbilder från en ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... ... all, Water For Empowerment ™ attracts volunteers together who want to combine ... empowering women as key stakeholders in the process. The non-profit launched its first ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the traditional and far-infrared ... traditional and far-infrared saunas. , For traditional saunas, Finnleo is offering ... sauna wood, and Finnleo uses only European Grade A Nordic White Spruce from sustainably ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... direct sauna parts and accessories. , Sauna accessories help improve the bather experience ... and personality. From basic styles for the purist looking for simplicity in design ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, ... Union (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, civil ... for the opening of the 5th African Network for Drugs and Diagnostics Innovation, ...
(Date:11/25/2015)... TX (PRWEB) , ... November 25, 2015 , ... For ... the companies’ “ Two Organizations, One Beat ” campaign. The partnership between the two ... services to aid in MAP International’s cause. , MAP International was founded in 1954 ...
Breaking Medicine News(10 mins):